Extrait

To confirm the efficacy of the Coartem pediatric formulation in infants and children with a body weight of ≥5 kg and <35 kg suffering from P. falciparum malaria by testing the hypothesis that Coartem 6-dose regimen pediatric formulation is non-inferior to the presently used Coartem 6-dose regimen of crushed conventional tablet formulation on the 28-day Polymerase Chain Reaction (PCR)-corrected parasitological cure rate.

Critère d'inclusion

• This study will evaluate the safety and efficacy of artemether-lumefantrine against uncomplicated malaria caused by Plasmodium falciparum in children

Liens

• euctr